Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,272 total articles
Stran & Company, Inc. reported strong fiscal 2025 financial results with $116.2 million in sales, a 40.6% increase from 2024, and positive EBITDA of $0.2 million compared to a loss in the prior year. Revenue growth was driven by 12.9% organic growth in the core promotional products segment and a significant sales increase from the acquired Gander G…
Burke & Herbert Financial Services Corp. and LINKBANCORP, Inc., both Nasdaq-listed US community bank holding companies, have received shareholder approval to merge, with Burke & Herbert as the surviving entity. The merger aims to enhance financial solutions across multiple states in the Mid-Atlantic region and is subject to regulatory approvals and…
SeaStar Medical reported 2025 financial results highlighting significant progress in clinical trials for its Selective Cytopheretic Device (SCD) therapy for Acute Kidney Injury (AKI), expanding the QUELIMMUNE therapy's adoption in top pediatric hospitals, and preparing for FDA approvals. The company achieved over 50% enrollment in the pivotal NEUTR…
Parsons Corporation has been appointed lead designer for the $389 million design-build project to improve I-64 Hampton Roads Express Lanes in Virginia. This initiative aims to fill a critical gap in the existing toll lane system, enhance travel reliability, reduce congestion, and complete a continuous 45-mile regional express lane network through N…
Casella Waste Systems, a regional solid waste, recycling, and resource management company, announced that its management will present at the upcoming Gabelli Funds 12th Annual Waste and Sustainability Symposium on April 9, 2026. Presentation materials will be made available on the company's investor website prior to the event.
Equillium, a clinical-stage biotech focused on immunobiology therapies for autoimmune and inflammatory diseases, reported Q4 and full year 2025 financial results. The company completed two financings totaling $85 million, bolstering cash reserves to $30.3 million as of year-end plus $35 million raised in March 2026, expected to fund operations thro…
Celcuity Inc. announced the FDA acceptance and priority review of its New Drug Application for gedatolisib targeting HR+/HER2-/PIK3CA wild-type advanced breast cancer with a PDUFA date of July 17, 2026. Positive Phase 3 trial results from the PIK3CA WT cohort showed significant improvement in progression-free survival and well-being measures. Topli…
Journey Medical Corporation reported a 10% revenue increase in FY2025 to $61.9 million, fueled by the successful launch and commercialization of Emrosi™, a treatment for rosacea. The company improved gross margins and achieved an adjusted EBITDA of $2.9 million, signaling financial strengthening despite a net loss of $11.4 million. Emrosi™ expanded…
Colliers International Group Inc. completed a private placement of C$550 million (approx. US$400 million) in 4.73% fixed rate senior unsecured notes due 2033. The funds will be used primarily for general corporate purposes, including repayment of borrowings under their revolving credit facility, enhancing financial flexibility to support long-term …
Cibus, Inc., an ag-tech company specializing in gene editing for plant traits, announced a planned underwritten public offering of Class A common stock and pre-funded warrants. The company intends to use the net proceeds for working capital and to advance its weed management traits in rice. The offering is subject to market conditions and includes …
Nkarta, Inc. reported its fourth quarter and full year 2025 financial results, highlighting progress in its NKX019 clinical trials for autoimmune diseases with dose escalation to 4 billion cells per dose. Initial clinical data presentations are planned for 2026, supported by a strong cash position of $295.1 million expected to fund operations throu…
ProKidney Corp. appoints Greg Madison as Chief Commercial Officer to lead commercial strategy for rilparencel, a novel cell therapy targeting chronic kidney disease (CKD) patients with diabetes. Madison's extensive biopharmaceutical leadership experience positions the company for advanced commercialization ahead of Phase 3 trial readouts.
Kratos Defense & Security Solutions has appointed David King, an experienced aerospace and defense executive, to its Board of Directors. King's extensive background includes leading Dynetics and serving as Group President at Leidos Dynetics. His expertise in defense technologies aligns with Kratos' focus areas such as unmanned systems and hypersoni…
E-Power Inc., listed on NASDAQ as EPOW, announced a strategic expansion into Vietnam through a partnership with ATSC SOLARTECH to establish a local production hub for anode materials targeting Artificial Intelligence Data Centers and energy storage systems. This move enhances supply chain resilience outside China, leverages tariff benefits, and sup…
Eldorado Gold Corporation announced that proxy advisory firm Institutional Shareholder Services (ISS) recommends shareholders vote in favor of the proposed arrangement to acquire Foran Mining Corporation. The transaction involves Eldorado issuing shares to Foran shareholders and aims to strengthen Eldorado's long-term growth via a value-focused mer…
Daktronics has installed a state-of-the-art 11,300+ square foot video display at the Seattle Mariners' T-Mobile Park, significantly enhancing the in-stadium digital experience for fans. The upgraded center field display features advanced technology for vibrant visuals and multiple content zones, reinforcing Daktronics' leadership in sports venue di…
Tevogen Bio Holdings Inc. has regained compliance with Nasdaq's minimum $1.00 bid price requirement, ensuring continued listing on the Nasdaq Global Market. The company is progressing its integrated healthcare model combining immunotherapy, AI, and capital discipline, and is exploring strategic acquisitions to pivot towards a cash-flow-positive ope…
IP Strategy Holdings, Inc. announces the continued growth of tokenized K-culture intellectual property assets via WAVIST, a regulated real-world asset investment platform converting entertainment IP rights into investable onchain assets. WAVIST completed a $3.22 million first asset sale round and is structuring a new $15 million fund, expanding fro…
ServisFirst Bancshares, Inc., a U.S.-based bank holding company, announces its upcoming earnings and operational results for Q1 2026, to be published on April 20, 2026. The company will host a live webcast discussing the results, underscoring its regional financial services operations across multiple southeastern states.
Toll Brothers announced the last opportunity to purchase new homes at Vista Rose, a luxury community in Placentia, California. Only a few homes remain, including two fully decorated and landscaped model homes priced from $1.9 million. The homes feature upscale finishes, modern layouts, and prime location benefits near shopping, dining, and transpor…
Onconetix announces that Realbotix's humanoid robot, its first enterprise sale, was featured as a live connected endpoint in Ericsson's first-ever pre-standard 6G over-the-air trial conducted in the U.S. The demonstration showcased Realbotix’s AI-agnostic humanoid robot transmitting real-time video and interaction over Ericsson’s test network, high…
Toll Brothers, a leading US luxury home builder, announced a new luxury community named MeadowRock in Douglas County near Parker, Colorado. Featuring large home sites with customizable floor plans ranging from 3,353 to 6,073 square feet and prices starting at $1.4 million, MeadowRock aims to attract buyers seeking spacious and personalized luxury h…
Toll Brothers, Inc. (NYSE:TOL), a leading national luxury home builder, announced the final opportunity to purchase new homes at its Lakeview Estates community in Lehi, Utah. With just four homes remaining, including a fully furnished model home, the community offers luxury single-story and two-story homes priced from $1.15 million. Residents will …
Denali Therapeutics announced that the U.S. FDA has granted accelerated approval for AVLAYAH™ (tividenofusp alfa-eknm), a novel enzyme replacement therapy designed to cross the blood-brain barrier to treat neurological symptoms of Hunter syndrome (MPS II). This marks the first FDA-approved treatment targeting the brain manifestations of this rare g…
GH Research PLC announced the peer-reviewed publication of its Phase 2b clinical trial results for GH001 (mebufotenin) in treatment-resistant depression (TRD) in JAMA Psychiatry. The study demonstrated significant efficacy and safety of GH001, with remission rates independent of the number of prior antidepressant treatment failures, a notable break…
